Indocyanine Green Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting indocyanine green clinical trials across 5 countries. Studies span Not Applicable, Phase 2. Top locations include Alkmaar, Netherlands, Amersfoort, Netherlands, Goyang-si, South Korea. Updated daily from ClinicalTrials.gov.


Indocyanine Green Trials at a Glance

7 actively recruiting trials for indocyanine green are listed on ClinicalTrialsFinder across 6 cities in 5 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Alkmaar, Amersfoort, and Goyang-si. Lead sponsors running indocyanine green studies include Isabelle Henskens, Cukurova University, and Federico II University.

Browse indocyanine green trials by phase

Treatments under study

About Indocyanine Green Clinical Trials

Looking for clinical trials for Indocyanine Green? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Indocyanine Green trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Indocyanine Green clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting

The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological Cancer

Cervical CancerEndometrial CancerIndocyanine Green (ICG)+1 more
Cukurova University30 enrolled1 locationNCT07380698
Recruiting
Not Applicable

Finding Sentinel Lymph Nodes During Mastectomy Using Indocyanine Green (INIGMA Study)

Breast CancerMastectomySentinel Lymph Node Biopsy (SLNB)+7 more
Isabelle Henskens90 enrolled2 locationsNCT07362485
Recruiting
Not Applicable

Implementation of Indocyanine Green to Identify Sentinel Lymph Nodes During Surgery for Breast Cancer

Breast CancerSentinel Lymph Node Biopsy (SLNB)Sentinel Lymph Node Detection+6 more
Isabelle Henskens1,760 enrolled7 locationsNCT07146295
Recruiting
Not Applicable

Sentinel Node and Organ-sparing Surgery in Stage I Colon Carcinoma

Sentinel Lymph NodeIndocyanine Green (ICG)Colon Cancer+9 more
Meander Medical Center341 enrolled1 locationNCT06652672
Recruiting

The Use of Indocyanine Green Fluorescence (ICG) During Laparoscopic Heller- Dor

achalasiaIndocyanine Green (ICG)Indocyanine Green+1 more
Federico II University70 enrolled1 locationNCT07181070
Recruiting
Phase 2

Photo-medicine-Guided Dual Approach for Reoperation of Sentinel Lymph Nodes in Locally Recurrent Breast Cancer Patients

Breast CancerSentinel Lymph Node Biopsy (SLNB)Locally Recurrent Breast Cancer+2 more
National Cancer Center, Korea30 enrolled1 locationNCT06780748
Recruiting
Not Applicable

Atomized Inhalation ICG for Treatment of Congenital Lung Malformations

Thoracoscopic SurgeryChildrenPulmonary Sequestration+2 more
Jiexiong Feng50 enrolled1 locationNCT06302985